Costanzo A - Search Results

1

The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene.

Papoutsaki M, Lanza M, Marinari B, Nisticò S, Moretti F, Levrero M, Chimenti S, Costanzo A. Papoutsaki M, et al. Among authors: costanzo a. J Invest Dermatol. 2004 Dec;123(6):1162-8. doi: 10.1111/j.0022-202X.2004.23498.x. J Invest Dermatol. 2004. PMID: 15610529 Free article.

2

Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.

Natoli G, Avantaggiati ML, Chirillo P, Costanzo A, Artini M, Balsano C, Levrero M. Natoli G, et al. Among authors: costanzo a. Mol Cell Biol. 1994 Feb;14(2):989-98. doi: 10.1128/mcb.14.2.989-998.1994. Mol Cell Biol. 1994. PMID: 7507209 Free PMC article.

3

Resistance to Fas-mediated apoptosis in human hepatoma cells.

Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C, Levrero M. Natoli G, et al. Among authors: costanzo a. Oncogene. 1995 Sep 21;11(6):1157-64. Oncogene. 1995. PMID: 7566976

4

Detection of replicative intermediates of viral RNA in peripheral blood mononuclear cells from chronic hepatitis C virus carriers.

Artini M, Natoli G, Avantaggiati ML, Balsano C, Chirillo P, Costanzo A, Bonavita MS, Levrero M. Artini M, et al. Among authors: costanzo a. Arch Virol Suppl. 1993;8:23-9. doi: 10.1007/978-3-7091-9312-9_3. Arch Virol Suppl. 1993. PMID: 8260868

5

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

Artini M, Natoli C, Tinari N, Costanzo A, Marinelli R, Balsano C, Porcari P, Angelucci D, D'Egidio M, Levrero M, Iacobelli S. Artini M, et al. Among authors: costanzo a. J Hepatol. 1996 Aug;25(2):212-7. doi: 10.1016/s0168-8278(96)80076-6. J Hepatol. 1996. PMID: 8878784

6

Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway.

Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M. Natoli G, et al. Among authors: costanzo a. Science. 1997 Jan 10;275(5297):200-3. doi: 10.1126/science.275.5297.200. Science. 1997. PMID: 8985011

7

Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase.

Natoli G, Costanzo A, Moretti F, Fulco M, Balsano C, Levrero M. Natoli G, et al. Among authors: costanzo a. J Biol Chem. 1997 Oct 17;272(42):26079-82. doi: 10.1074/jbc.272.42.26079. J Biol Chem. 1997. PMID: 9334169 Free article.

8

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling.

Natoli G, Costanzo A, Guido F, Moretti F, Levrero M. Natoli G, et al. Among authors: costanzo a. Biochem Pharmacol. 1998 Oct 15;56(8):915-20. doi: 10.1016/s0006-2952(98)00154-3. Biochem Pharmacol. 1998. PMID: 9776301 Review.

9

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G. De Laurenzi V, et al. Among authors: costanzo a. J Exp Med. 1998 Nov 2;188(9):1763-8. doi: 10.1084/jem.188.9.1763. J Exp Med. 1998. PMID: 9802988 Free PMC article.

10

Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2.

Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, Burgio VL, Agresti C, Levrero M. Natoli G, et al. Among authors: costanzo a. J Biol Chem. 1998 Nov 20;273(47):31262-72. doi: 10.1074/jbc.273.47.31262. J Biol Chem. 1998. PMID: 9813034 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

851 results

Search Page

Filters